Lunit to Showcase 9 AI-based Research Results at ESMO 2023
– 9 abstracts accepted by the ESMO annual meeting – unveiling insights into cancer analysis, immunotherapy response, and predictive biomarkers at ESMO 2023 SEOUL, South Korea, Oct. 10, 2023 /PRNewswire/ — Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the presentation of 9 studies featuring its AI pathology […]